Photo Illustration: Sarah Grillo/Axios. Photo: Carl Court/Getty Images

President Trump's style of politics thrives when chaos destabilizes institutions, and that's exactly what's happening now.

Why it matters: Trump's campaign is already arguing that Democrats can’t be trusted to lead if they can’t even get a couple hundred thousand counts done right, and none of the Democratic candidates campaigning today are boasting of an Iowa win.

  • And the Trump campaign's attacks on health care — arguing Iowa proves Democrats can't be trusted to run big new programs like Medicare for All — are getting traction with conservatives. “No, but seriously, let us run your healthcare,” tweeted Townhall.com political editor Guy Benson.

There are plenty of reasons to question whether caucuses make sense and whether Iowa should remain the first contest, from the state's demographics to how hard it is for people who work at night or have kids or aging parents to spend hours on a weeknight picking candidates.

The problems were magnified this year, first when the Des Moines Register scrapped its final poll because of concerns over methodology, and then when last night's technical problems prevented a release of the results.

  • These issues can be weaponized to underscore questions about the reliability of the press and polls, the caucuses themselves, and, by extension, elections.
“Democrats are stewing in a caucus mess of their own creation with the sloppiest train wreck in history. It would be natural for people to doubt the fairness of the process."
— Brad Parscale, Trump 2020 campaign manager

Iowa's problems also mask real, underlying concerns:

  • Its status as a swing state is increasingly debatable. Trump won by 9+ points in 2016, the GOP controls the state government, and demographics make competing for its six electoral votes a less obvious priority than some bigger, more diverse states.
  • Meanwhile, many of the candidates, including Joe Biden, have never been poised to perform well in Iowa.

To be sure, the new app and the phone system and the plan to release three sets of data were not ready for prime time. But they were instituting these changes in a good faith effort to modernize, and in no small part because of Bernie Sanders and his backers’ calls to change the old process.

The bottom line: The errors robbed Sanders and possibly Pete Buttigieg of a victory speech, kept Democrats from getting clarity on the viability of Biden and Buttigieg, and opened up a new avenue of attack for a president that thrives on chaos.

Go deeper

Updated 15 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Global: Total confirmed cases as of 6:30 p.m. ET: 20,177,521 — Total deaths: 738,716 — Total recoveries: 12,400,156Map.
  2. U.S.: Total confirmed cases as of 6:30 p.m. ET: 5,130,784 — Total deaths: 164,603 — Total recoveries: 1,670,755 — Total tests: 62,513,174Map.
  3. States: Georgia reports 137 coronavirus deaths, setting new daily record Florida reports another daily record for deaths.
  4. Health care: Trump administration buys 100 million doses of Moderna's coronavirus vaccine.
  5. Business: Moderna reveals it may not hold patent rights for vaccine.
  6. Sports: Big Ten scraps fall football season.

Voters cast ballots in Minnesota, Georgia, Connecticut, Wisconsin and Vermont

Photo: Spencer Platt/Getty Images

Primary elections are being held on Tuesday in Minnesota, Georgia, Connecticut, Vermont and Wisconsin.

The big picture: Georgia and Wisconsin both struggled to hold primaries during the coronavirus pandemic, but are doing so again — testing their voting systems ahead of the general election. Rep. Ilhan Omar (D-Minn.) is facing a strong challenger as she fights for her political career. In Georgia, a Republican primary runoff pits a QAnon supporter against a hardline conservative.

44 mins ago - Health

Trump administration buys 100 million doses of Moderna's vaccine

A volunteer in Moderna's vaccine clinical trial receives a shot. Photo: Paul Hennessy/NurPhoto via Getty Images

The U.S. government has agreed to buy 100 million doses of Moderna's experimental coronavirus vaccine for $1.5 billion, or $15 per dose.

Why it matters: The Trump administration, through Operation Warp Speed, has now bought initial batches of vaccines from Moderna, GlaxoSmithKline and Sanofi, Pfizer, Novavax, Johnson & Johnson and AstraZeneca before knowing whether they are safe and effective. The federal government also appears to own some of the patent rights associated with Moderna's vaccine.